The aim of this study was to assess the added benefit of newborn genetic screening for GJB2 and SLC26A4 variants in conjunction with newborn hearing screening in a large cohort of children followed for hearing loss at a Canadian pediatric tertiary healthcare center. Here, SLC26A4 is linked to hearing loss disorder.